Obligation Goldman & Sachs 5% ( US38141E3G26 ) en USD

Goldman & Sachs

100 % ▲

Etas-Unis

US38141E3G26 ( en USD )

5% par an ( paiement semestriel )

15/09/2025

Prospectus brochure de l'obligation Goldman Sachs US38141E3G26 en USD 5%, échéance 15/09/2025

1 000 USD

17 784 000 USD

38141E3G2

BBB+ ( Qualité moyenne inférieure )

A2 ( Qualité moyenne supérieure )

15/09/2025 ( Dans 114 jours )

Goldman Sachs est une banque d'investissement multinationale américaine offrant des services financiers tels que la banque d'investissement, la gestion d'actifs, la gestion de patrimoine et la vente et négociation de titres.

L'Obligation émise par Goldman & Sachs ( Etas-Unis ) , en USD, avec le code ISIN US38141E3G26, paye un coupon de 5% par an.
Le paiement des coupons est semestriel et la maturité de l'Obligation est le 15/09/2025

L'Obligation émise par Goldman & Sachs ( Etas-Unis ) , en USD, avec le code ISIN US38141E3G26, a été notée A2 ( Qualité moyenne supérieure ) par l'agence de notation Moody's.

L'Obligation émise par Goldman & Sachs ( Etas-Unis ) , en USD, avec le code ISIN US38141E3G26, a été notée BBB+ ( Qualité moyenne inférieure ) par l'agence de notation Standard & Poor's ( S&P ).

Pricing Supplement No. 519 dated September 7, 2010
Page 1 of 14
424B2 1 d424b2.htm PRICING SUPPLEMENT NO. 519 DATED SEPTEMBER 7, 2010
Table of Contents
Filed Pursuant to Rule 424(b)(2)
Registration Statement No. 333-154173

Pricing Supplement to the Prospectus dated April 6, 2009 and the
Prospectus Supplement dated April 6, 2009 -- No. 519

$17,784,000

The Goldman Sachs Group, Inc.

5.00% Notes due 2025

Medium-Term Notes, Series D

We will pay you interest on your notes on a monthly basis at a rate of 5.00% per annum on the 15 of each month.
th
The first such payment will be made on October 15, 2010.
If requested, we will redeem the notes prior to their stated maturity date upon the death of a beneficial owner who
has owned the notes for at least six months. We call this feature the survivor's option. The survivor's option is subject to a
limit of $250,000 on the permitted principal amount exercisable by the estate of the deceased beneficial owner in any
calendar year and to a limit of two percent of the principal amount of all outstanding notes offered by this pricing
supplement in any calendar year. We may waive those limits in our discretion. Any notes accepted for repayment through
the exercise of the survivor's option normally will be repaid on the earlier of the June 15th or December 15 inter
th
est
payment date that occurs 60 or more calendar days after the date of acceptance.
A valid redemption request requires the representative of the deceased beneficial owner to provide the information
described on page PS-5 to the Trustee, together with a properly completed redemption request in the form of Appendix A
to this pricing supplement. See "Additional Information About the Notes -- Survivor's Option to Request Repayment" on
page PS-3 for more information.

Per Note
Total
Initial public offering price

100.00%
$ 17,784,000
Underwriting discount

3.05%
$
542,412
Proceeds, before expenses, to The Goldman Sachs Group, Inc.

96.95%
$ 17,241,588

The initial public offering price set forth above does not include accrued interest, if any. Interest on the notes will
accrue from September 10, 2010 and must be paid by the purchaser if the notes are delivered after September 10, 2010.
Neither the Securities and Exchange Commission nor any other regulatory body has approved or
disapproved of these securities or passed upon the accuracy or adequacy of this pricing supplement. Any
representation to the contrary is a criminal offense.
The notes are not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any
other governmental agency, nor are they obligations of, or guaranteed by, a bank.

Goldman Sachs may use this pricing supplement, the accompanying prospectus supplement and the accompanying
prospectus in the initial sale of the notes. In addition, Goldman, Sachs & Co. or any other affiliate of Goldman Sachs may
use this pricing supplement, the accompanying prospectus supplement and the accompanying prospectus in a market-
making transaction in the notes after their initial sale. Unless Goldman Sachs or its agent informs the purchaser otherwise
in the confirmation of sale, this pricing supplement, the accompanying prospectus supplement and the accompanying
http://www.sec.gov/Archives/edgar/data/886982/000119312510206599/d424b2.htm
9/8/2010

Pricing Supplement No. 519 dated September 7, 2010
Page 2 of 14
prospectus are being used in a market-making transaction.

Goldman, Sachs & Co.
Incapital LLC

Pricing Supplement dated September 7, 2010.
http://www.sec.gov/Archives/edgar/data/886982/000119312510206599/d424b2.htm
9/8/2010

Pricing Supplement No. 519 dated September 7, 2010
Page 3 of 14
Table of Contents
SPECIFIC TERMS OF THE NOTES

Please note that in this section entitled "Specific Terms of the Notes", references to "The Goldman Sachs
Group, Inc.", "we", "our" and "us" mean only The Goldman Sachs Group, Inc. and do not include its
consolidated subsidiaries. Also, in this section, references to "holders" mean The Depository Trust
Company (DTC) or its nominee and not indirect owners who own beneficial interests in notes through
participants in DTC. Please review the special considerations that apply to indirect owners in the
accompanying prospectus, under "Legal Ownership and Book-Entry Issuance".
This pricing supplement no. 519 dated September 7, 2010 (pricing supplement) and the accompanying prospectus
dated April 6, 2009 (accompanying prospectus), relating to the notes, should be read together. Because the notes are part
of a series of our debt securities called Medium-Term Notes, Series D, this pricing supplement and the accompanying
prospectus should also be read with the accompanying prospectus supplement, dated April 6, 2009 (accompanying
prospectus supplement). Terms used but not defined in this pricing supplement have the meanings given them in the
accompanying prospectus or accompanying prospectus supplement, unless the context requires otherwise.
The notes are a separate series of our debt securities under our Medium-Term Notes, Series D program governed by
our Senior Debt Indenture, dated as of July 16, 2008 (2008 Indenture), between us and The Bank of New York Mellon, as
trustee (Trustee). This pricing supplement summarizes specific terms that will apply to your notes. The terms of the notes
described here supplement those described in the accompanying prospectus supplement and accompanying prospectus
and, if the terms described here are inconsistent with those described there, the terms described here are controlling.
Terms of the 5.00% Notes due 2025

Issuer: The Goldman Sachs Group, Inc.
described under "Additional Information About the Notes
Principal amount: $17,784,000
-- Survivor's Option to Request Repayment"
Specified currency: U.S. dollars ($)
Listing: None
Type of Notes: Fixed rate notes (notes)
ERISA: as described under "Employee Retirement
Denominations: $1,000 and integral multiples of $1,000
Income Security Act" on page 143 of the accompanying
thereof
prospectus
Trade date: September 7, 2010
CUSIP no.: 38141E3G2
Original issue date: September 10, 2010
Form of notes: Your notes will be issued in book-entry
form and represented by a master global note.
Stated maturity date: September 15, 2025
You should read the section "Legal Ownership and
Interest rate: 5.00% per annum
Book-Entry Issuance" in the accompanying prospectus
Original issue discount (OID): not applicable
for more information about notes issued in book-entry
Interest payment dates: the 15 of each mo
th
nth,
form
commencing on October 15, 2010
Defeasance applies as follows:
Regular record dates: the first day of each month

· full defeasance -- i.e. , our right to be relieved
Day count convention: 30/360 (ISDA)

of all our obligations on the note by placing
Business day: New York
funds in trust for the investor: yes

Business day convention: following unadjusted
· covenant defeasance -- i.e. , our right to be
Redemption at option of issuer before stated

relieved of specified provisions of the note by
maturity: not applicable
placing funds in trust for the investor: yes
Survivor's option to request repayment: the notes are
FDIC: The notes are not bank deposits and are not
subject to repayment prior to the stated maturity upon
insured by the Federal Deposit Insurance Corporation or
the death of a beneficial owner who owned the notes for
any other governmental agency, nor are they obligations
at least six months, if requested, subject to certain
of, or guaranteed by, a bank.
limitations, as

PS-2
http://www.sec.gov/Archives/edgar/data/886982/000119312510206599/d424b2.htm
9/8/2010

Pricing Supplement No. 519 dated September 7, 2010
Page 4 of 14
Table of Contents
ADDITIONAL INFORMATION ABOUT THE NOTES
Book-Entry System
We will issue the notes as a master global note registered in the name of DTC, or its nominee. The sale of the notes
will settle in immediately available funds through DTC. You will not be permitted to withdraw the notes from DTC except in
the limited situations described in the accompanying prospectus under "Legal Ownership and Book-Entry Issuance --
What Is a Global Security? -- Holder's Option to Obtain a Non-Global Security; Special Situations When a Global Security
Will Be Terminated". Investors may hold interests in a master global note through organizations that participate, directly or
indirectly, in the DTC system.
Survivor's Option to Request Repayment
Following the death of the beneficial owner of a note, so long as that note was owned by that beneficial owner or the
estate of that beneficial owner for at least six months prior to the request, if requested by the authorized representative of
the beneficial owner of that note (subject to the limitations described below), we agree to redeem any notes prior to the
stated maturity unless the notes:

· have been previously redeemed or otherwise repaid, or

· have been declared due and payable before their stated maturity by reason of an event of default under the

2008 Indenture, as more fully described in the accompanying prospectus under "Description of Debt Securities
We May Offer -- Default, Remedies and Waiver of Default".
Upon the valid exercise of the option to request repayment described in the preceding paragraph (Survivor's Option)
and the proper tender of that note for repayment (subject to the limitations described below), we will redeem that note, in
whole or in part (but in amounts of not less than $1,000), at a price equal to 100% of the principal amount of the note plus
any unpaid interest accrued to (but excluding) the date of repayment.
Incapital LLC has advised that it intends to make a market in the notes. Depending on market conditions, including
changes in interest rates, and our creditworthiness, the value of the notes may be greater than their principal amount plus
any unpaid interest accrued. Accordingly, the authorized representative should contact Incapital LLC to determine
the market price of the notes and should otherwise carefully consider whether to sell the notes to Incapital LLC
or another market participant rather than redeeming the notes at the principal amount plus accrued interest
pursuant to a request for redemption.
To be valid, the Survivor's Option must be exercised by or on behalf of the person who has:

· authority to act on behalf of the deceased beneficial owner of the note, including, without limitation, the personal

representative or executor of the deceased beneficial owner or the surviving joint owner with the deceased
beneficial owner, under the laws of the applicable jurisdiction, and

· the right to sell, transfer or otherwise dispose of an interest in a note and the right to receive the proceeds from

the note, as well as the principal and interest payable to the holder of the note.

PS-3
http://www.sec.gov/Archives/edgar/data/886982/000119312510206599/d424b2.htm
9/8/2010

Pricing Supplement No. 519 dated September 7, 2010
Page 5 of 14
Table of Contents
The following will be deemed the death of a beneficial owner of a note, and the entire principal amount of the note so
held will be subject to redemption by us upon request (with the limitations described below):

· death of a person holding a beneficial ownership interest in a note as a joint tenant or tenant by the entirety with

another person, a tenant in common with the deceased holder's spouse or a tenant in common with a person
other than such deceased person's spouse;

· death of a person who at the time of his or her death was a beneficiary of a revocable or irrevocable trust that
holds a beneficial ownership interest in a note may, in the discretion of the Trustee, be deemed the death of a

beneficial owner of that note, if such beneficial trust interest can be established to the satisfaction of us and the
Trustee; and

· death of a person who, at the time of his or her death, was entitled to substantially all of the beneficial ownership

interests in a note regardless of whether that beneficial owner was the registered holder of that note, if
entitlement to those interests can be established to the satisfaction of us and the Trustee.
In addition, a beneficial ownership interest will be deemed to exist:

· in typical cases of nominee ownership, ownership under the Uniform Transfers to Minors Act or Uniform Gifts to

Minors Act, community property or other joint ownership arrangements between a husband and wife; and

· in custodial and trust arrangements where one person has all of the beneficial ownership interests in the

applicable note at the time of his or her death.
We have the discretionary right to limit the aggregate principal amount of notes as to which exercises of the
Survivor's Option shall be accepted by us from authorized representatives:

· of all deceased beneficial owners in any calendar year to an amount equal to 2% of the principal amount of all

outstanding notes offered by this pricing supplement as of the end of the most recent calendar year (two percent
aggregate limitation); and

· of any individual deceased beneficial owner of notes to $250,000 in any calendar year ($250,000 limitation).
In addition, we will not permit the exercise of the Survivor's Option except in principal amounts of $1,000 and integral
multiples of $1,000 in excess thereof.
We may, at our option, redeem interests of any deceased beneficial owner in the notes in any calendar year in
excess of the $250,000 limitation. Any optional redemption by us of this kind, to the extent it exceeds the $250,000
limitation for any deceased beneficial owner, will not be included in the computation of the two percent aggregate
limitation for redemption of the notes for that or any other calendar year.
We may also, at our option, redeem interests of deceased beneficial owners in the notes in any calendar year in an
aggregate principal amount exceeding the two percent aggregate limitation. Any optional redemption by us of this kind, to
the extent it exceeds the two percent aggregate limitation, will not be considered in calculating the two percent aggregate
limitation for any other calendar year.
Furthermore, any optional redemption by us with respect to a deceased beneficial owner's interest in the notes is
inapplicable with respect to any other deceased beneficial owner's interest in the notes. In

PS-4
http://www.sec.gov/Archives/edgar/data/886982/000119312510206599/d424b2.htm
9/8/2010

Pricing Supplement No. 519 dated September 7, 2010
Page 6 of 14
Table of Contents
other words, we may waive any applicable limitations with respect to a deceased beneficial owner but not make the same
or similar waivers with respect to other deceased beneficial owners.
Each election to exercise the Survivor's Option will be accepted in the order that elections are received by the
Trustee, except for any note the acceptance of which would contravene either the two percent aggregate limitation or the
$250,000 limitation. Upon any determination by us to redeem notes in excess of the $250,000 limitation or the two percent
aggregate limitation, notes will be redeemed in the order of receipt of redemption requests by the Trustee. Each tendered
note that is not accepted in any calendar year due to the application of either the two percent aggregate limitation or the
$250,000 limitation will be deemed to be tendered in the following calendar year in the order in which all such notes were
originally tendered.
Notes accepted for repayment through the exercise of the Survivor's Option normally will be redeemed on the earlier
of the June 15 or
th
December 15 inter
th
est payment date that occurs 60 or more calendar days after the date of the
acceptance. For example, if the acceptance date of a note tendered through a valid exercise of the Survivor's Option is
May 1, 2011, and interest on that note is paid monthly on the 15 o
th
f every month, we would normally, at our option, repay
that note on the interest payment date occurring on December 15, 2011, because the June 15, 2011 interest payment
date would occur less than 60 days from the date of acceptance. Any redemption request may be withdrawn by the
person(s) presenting the request upon delivery of a written request for withdrawal given by the participant on behalf of the
person(s) to the Trustee not less than 30 days before the redemption date. If a note tendered through a valid exercise of
the Survivor's Option is not accepted, the Trustee will deliver a notice by first-class mail to the participant through whom
the note was tendered that states the reason that note has not been accepted for redemption.
With respect to notes represented by a master global note (such as these notes), DTC or its nominee is the
depositary and is treated as the holder of the notes and the institution that has an account with the depositary of the notes
is referred to as the "participant".
To obtain redemption pursuant to exercise of the Survivor's Option for a note, the deceased beneficial owner's
authorized representative must provide the following items to the participant in DTC through which the beneficial interest
in the note is held by the deceased beneficial owner:

· a written request for redemption signed by the authorized representative of the deceased beneficial owner with
the signature guaranteed by a member firm of a registered national securities exchange or of the Financial

Institution Regulatory Authority, Inc. (FINRA) or a commercial bank or trust company having an office or
correspondent in the United States and a written instruction to notify the Trustee of the authorized
representative's desire to obtain redemption pursuant to exercise of the Survivor's Option;

· appropriate evidence satisfactory to us and the Trustee:

(a)
that the deceased was the beneficial owner of the note at the time of death and his or her interest in the

note was owned by the deceased beneficial owner or his or her estate for at least six months prior to the
request for redemption,

(b)
that the death of the beneficial owner has occurred,

(c)
of the date of death of the beneficial owner, and

(d)
that the representative has authority to act on behalf of the beneficial owner;

PS-5
http://www.sec.gov/Archives/edgar/data/886982/000119312510206599/d424b2.htm
9/8/2010

Pricing Supplement No. 519 dated September 7, 2010
Page 7 of 14
Table of Contents

· if applicable, a properly executed assignment or endorsement;

· tax waivers and any other instruments or documents that we or the Trustee reasonably require in order to

establish the validity of the beneficial ownership of the note and the claimant's entitlement to payment;

· any additional information we or the Trustee reasonably require to evidence satisfaction of any conditions to the

exercise of the Survivor's Option or to document beneficial ownership or authority to make the election and to
cause the redemption of the note; and

· if the interest in the note is held by a nominee of the deceased beneficial owner, a certificate satisfactory to us

and the Trustee from the nominee attesting to the deceased's beneficial ownership of such note.
After the representative provides the information to the participant, the participant will then deliver each of these
items to the Trustee, and to Goldman, Sachs & Co. in its capacity as administrator of the Survivor's Option on our behalf,
together with evidence satisfactory to us and the Trustee from the participant stating that it represents the deceased
beneficial owner. The participant will then need to deliver to the Trustee a request for redemption substantially in the form
attached as Appendix A to this pricing supplement.
All questions regarding the eligibility or validity of any exercise of the Survivor's Option will be determined by us, in
our sole discretion, which determination will be final and binding on all parties.
Subject to arrangements with the depositary, payment for interests in the notes to be redeemed will be made to the
depositary in the aggregate principal amount specified in the redemption requests submitted to the Trustee by the
depositary that are to be fulfilled in connection with the payment upon presentation of the notes to the Trustee for
redemption.
Additional redemption request forms for the exercise of the Survivor's Option may be obtained from the Trustee at
The Bank of New York Mellon at 2001 Bryan Street, 9th Floor, Dallas, TX 75201, Attention: Survivor Options Processing,
telephone: (800) 254-2826, fax: (241) 468-6405.
During any time in which the notes are not represented by a master global note and are issued in definitive form:

· all references in this section of the pricing supplement to participants and the depositary, including the

depositary's governing rules, regulations and procedures, will be deemed inapplicable;

· all determinations that the participants are required to make as described in this section will be made by us,
including, without limitation, determining whether the applicable decedent is in fact the beneficial owner of the

interest in the notes to be redeemed or is in fact deceased and whether the representative is duly authorized to
request redemption on behalf of the applicable beneficial owner; and

· all redemption requests, to be effective, must:

--
be delivered by the representative to the Trustee, with a copy to us;

--
if required by the Trustee and us, be in the form of the attached redemption request with appropriate

changes mutually agreed to by the Trustee and us to reflect the fact that the

PS-6
http://www.sec.gov/Archives/edgar/data/886982/000119312510206599/d424b2.htm
9/8/2010

Pricing Supplement No. 519 dated September 7, 2010
Page 8 of 14
Table of Contents
redemption request is being executed by a representative, including provision for signature guarantees;

and

--
be accompanied by the note that is the subject of the redemption request or, if applicable, a properly
executed assignment or endorsement, in addition to all documents that are otherwise required to

accompany a redemption request. If the record holder of the note is a nominee of the deceased beneficial
owner, a certificate or letter from the nominee attesting to the deceased's ownership of a beneficial
interest in the note must also be delivered.
U.S. Federal Income Tax Consequences
You should carefully consider, among other things, the matters set forth under "United States Taxation" in the
accompanying prospectus supplement and the accompanying prospectus. The following discussion supplements the
section "United States Taxation" in the accompanying prospectus supplement and the accompanying prospectus and is
subject to the limitations and exceptions set forth therein.
Medicare Tax. For taxable years beginning after December 31, 2012, a U.S. holder that is an individual or estate, or
a trust that does not fall into a special class of trusts that is exempt from such tax, is subject to a 3.8% tax on the lesser of
(1) the U.S. holder's "net investment income" for the relevant taxable year and (2) the excess of the U.S. holder's modified
adjusted gross income for the taxable year over a certain threshold (which in the case of individuals will be between
$125,000 and $250,000, depending on the individual's circumstances). A holder's net investment income will generally
include its interest income and its net gains from the disposition of notes, unless such interest payments or net gains are
derived in the ordinary course of the conduct of a trade or business (other than a trade or business that consists of certain
passive or trading activities). If you are a U.S. holder that is an individual, estate or trust, you are urged to consult your tax
advisors regarding the applicability of the Medicare tax to your income and gains in respect of your investment in the
notes.
Backup Withholding and Information Reporting. Please see the discussion under "United States Taxation -- Taxation
of Debt Securities -- Backup Withholding and Information Reporting" in the accompanying prospectus for a description of
the applicability of the backup withholding and information reporting rules to payments made on your notes. In addition,
pursuant to recently enacted legislation, certain payments in respect of the notes made to corporate U.S. holders after
December 31, 2011 may be subject to information reporting and backup withholding.

PS-7
http://www.sec.gov/Archives/edgar/data/886982/000119312510206599/d424b2.htm
9/8/2010

Pricing Supplement No. 519 dated September 7, 2010
Page 9 of 14
Table of Contents
SUPPLEMENTAL PLAN OF DISTRIBUTION
The Goldman Sachs Group, Inc. and the underwriters for this offering named below have entered into a terms
agreement and a distribution agreement with respect to the notes. Subject to certain conditions, each underwriter named
below has severally agreed to purchase the principal amount of notes indicated in the following table.

Principal Amount
Underwriters

of Notes
Goldman, Sachs & Co.

$
8,892,000
Incapital LLC

8,892,000

Total

$ 17,784,000

Notes sold by the underwriters to the public will initially be offered at the original issue price set forth on the cover of
this pricing supplement. The underwriters intend to purchase the notes from The Goldman Sachs Group, Inc. at a
purchase price equal to the original issue price less a discount of 3.05% of the principal amount of the notes. Any notes
sold by the underwriters to securities dealers may be sold at a discount from the original issue price of up to 1.60% of the
principal amount of the notes. Any such securities dealers may resell any notes purchased from the underwriters to
certain other brokers or dealers at a discount from the original issue price of up to 0.35% of the principal amount of the
notes. If all of the offered notes are not sold at the original issue price, the underwriters may change the offering price and
the other selling terms.
Please note that the information about the original issue price and net proceeds to The Goldman Sachs Group, Inc.
on the front cover page relates only to the initial sale of the notes. If you have purchased a note in a market-making
transaction by Goldman, Sachs & Co. or any other affiliate of The Goldman Sachs Group, Inc. after the initial sale,
information about the price and date of sale to you will be provided in a separate confirmation of sale.
Each underwriter has represented and agreed that it will not offer or sell the notes in the United States or to United
States persons except if such offers or sales are made by or through FINRA member broker-dealers registered with the
U.S. Securities and Exchange Commission.
The Goldman Sachs Group, Inc. estimates that its share of the total offering expenses, excluding underwriting
discounts and commissions, whether paid to Goldman, Sachs & Co. or any other underwriter, will be approximately
$472,500.
The provision regarding the market-making activities of Goldman, Sachs & Co. described under "Plan of Distribution
-- Market-Making Resales by Affiliates" on page 142 of the accompanying prospectus does not apply to the notes.
Goldman, Sachs & Co. does not intend to make a market in these notes. However, in the future, Goldman, Sachs & Co.
or other affiliates of The Goldman Sachs Group, Inc. may decide to repurchase and resell the notes in market-making
transactions, with resales being made at prices related to prevailing market prices at the time of resale or at negotiated
prices. For more information about the plan of distribution and possible market-making activities, see "Plan of Distribution"
in the accompanying prospectus and "Supplemental Plan of Distribution" in the accompanying prospectus supplement.
The notes are a new issue of securities with no established trading market. The Goldman Sachs Group, Inc. has
been advised by Incapital LLC that they intend to make a market in the notes. Incapital LLC is not obligated to do so and
may discontinue market-making at any time without notice. No assurance can be given as to the liquidity of the trading
market for the notes.

PS-8
http://www.sec.gov/Archives/edgar/data/886982/000119312510206599/d424b2.htm
9/8/2010

Pricing Supplement No. 519 dated September 7, 2010
Page 10 of 14
Table of Contents
The Goldman Sachs Group, Inc. has agreed to indemnify the several underwriters against certain liabilities, including
liabilities under the Securities Act of 1933.
Certain of the underwriters and their affiliates have in the past provided, and may in the future from time to time
provide, investment banking and general financing and banking services to The Goldman Sachs Group, Inc. and its
affiliates, for which they have in the past received, and may in the future receive, customary fees. The Goldman Sachs
Group, Inc. and its affiliates have in the past provided, and may in the future from time to time provide, similar services to
the underwriters and their affiliates on customary terms and for customary fees.
Conflicts of Interest
Goldman, Sachs & Co. is an affiliate of The Goldman Sachs Group, Inc. and, as such, has a "conflict of interest" in
this offering within the meaning of NASD Rule 2720. Consequently, the offering is being conducted in compliance with the
provisions of Rule 2720. Goldman, Sachs & Co. is not permitted to sell notes in this offering to an account over which it
exercises discretionary authority without the prior specific written approval of the account holder.

PS-9
http://www.sec.gov/Archives/edgar/data/886982/000119312510206599/d424b2.htm
9/8/2010